$ADCT
ADC Therapeutics SA
XNYS
Why is ADCT down today? It is at $0.965 (-3.16%), and our scanner flagged it 14 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ADCT spikes, and full due diligence on ADCT — key stats, earnings, dilution and insider activity. Free.
Get free $ADCT alerts the moment volume spikes
Our scanner flagged $ADCT 14 times in the last 30 days. Create a free account to track $ADCT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $0.965
- Change today
- -3.16%
- Previous close
- $0.997
- 52-week range
- $0.780 – $4.98
- Market cap
- $127M
- Institutional own.
- 64.77%
- Total held
- 70.0%
- Tradeable float
- 38.3M 30% of shares · after 5% insiders + 65% institutions
- Short interest
- 5.1M ▼ -8% vs prior · as of 2026-07-31
- Short % of float
- 13.3%
- Days to cover
- 6.1d
- Avg daily volume
- 1.2M
- Exchange
- XNYS
- 5mthin
- 0.1x
- 15mthin
- 0.1x
- 1hthin
- 0.1x
- 1D
- 0.2x
Get free ADCT + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ADCT down today?
Here is the latest on ADCT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ADCT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystADC Therapeutics SA: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedAug 14, 2026 · 10 days agoAnalyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying11 buys, 7 sells last 3 months (16/23 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mallik Ameet Officer | Acquired (grant/award) | +675K 0.5% of company | added 47% | 2.12M | n/a | Jun 30, 26 |
Carmona Jose Officer | Acquired (grant/award) | +204K 0.2% of company | added 28% | 938K | n/a | Jun 30, 26 |
Graham Peter J Officer | Acquired (grant/award) | +221K 0.2% of company | added 36% | 842K | n/a | Jun 30, 26 |
Zaki Mohamed Officer | Acquired (grant/award) | +214K 0.2% of company | added 31% | 896K | n/a | Jun 30, 26 |
Coughlin Timothy Director | Sold (automatic/other) | -13K | sold 15% | 72K | $39K at $3.08 | Jun 3, 26 |
Bizzari Jean-Pierre Director | Sold (automatic/other) | -13K | sold 8.3% | 139K | $39K at $3.08 | Jun 3, 26 |
Hug Peter Director | Sold (automatic/other) | -2K | sold 0.8% | 263K | $7K at $3.08 | Jun 3, 26 |
Monges Viviane Director | Sold (automatic/other) | -3K | sold 1.4% | 186K | $8K at $3.08 | Jun 3, 26 |
Sandor Victor Director | Sold (automatic/other) | -13K | sold 8.2% | 141K | $39K at $3.08 | Jun 3, 26 |
Squarer Ron Director | Sold (automatic/other) | -15K 0.01% of company | sold 11% | 123K | $47K at $3.08 | Jun 3, 26 |
Azelby Robert Director | Sold (automatic/other) | -13K | sold 10% | 113K | $39K at $3.08 | Jun 3, 26 |
Coughlin Timothy Director | Acquired (grant/award) | +45K 0.04% of company | added 100% | 85K | n/a | Jun 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $ADCT runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 29,109,196 new shares
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$ADCT Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ADCT Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
ADCT stock FAQ
Why is $ADCT down today?
Here is the latest on ADCT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ADCT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the ADCT stock price today?
ADCT last traded at $0.965, down 3.16% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live ADCT alerts?
The ADCT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ADCT 14 times in the last 30 days.
What exchange is ADCT on?
ADCT (ADC Therapeutics SA) trades on XNYS, with a market cap of about $127M.
Is ADCT good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ADCT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.